Rajasekaran Veerabadran
About Rajasekaran Veerabadran
Data last updated:
Rajasekaran Veerabadran is a Director at Sunglow Lifescience Private Limited (since 2013) and Director at Sunglow Pharmaceuticalss Private Limited (since 2013). The companies operate in Pharma and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹79.98 Cr; the largest is Sunglow Lifescience Private Limited at ₹68.84 Cr (FY 2025). Earlier, Rajasekaran Veerabadran was a Director at Adiramedica Private Limited (2024–2025) and Director at Relimed Pharmaceuticals Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunglow Lifescience Private Limited U24100TN2012PTC087894 | Director | 09 Sep 2013 | 2012 | ₹68.84 Cr (FY 2025) | Active |
 Sunglow Pharmaceuticalss Private Limited U24232PY2010PTC002407 | Director | 09 Sep 2013 | 2010 | ₹11.14 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Adiramedica Private Limited U72100KA2024FTC192583 | Director | 30 Aug 2024 | 2024 | Active | |
| Relimed Pharmaceuticals Private Limited U74990TN2011PTC078845 | Director | 01 Oct 2013 | 2011 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajasekaran Veerabadran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kamaraj | 02910388 | Sunglow Lifescience Private Limited , Sunglow Pharmaceuticalss Private Limited | Director |
| Narayanan Agaram Seetharaman | Sunglow Lifescience Private Limited | Company Secretary | |
| Rajasekar Nagamallu | 00328170 | Sunglow Lifescience Private Limited | Director |
| S Arvind Bhandari | 06748714 | Sunglow Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajasekaran Veerabadran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajasekaran Veerabadran
Rajasekaran Veerabadran currently holds 2 directorships: Sunglow Lifescience Private Limited (Director, since 09 Sep 2013, revenue ₹68.84 Cr (FY 2025)); Sunglow Pharmaceuticalss Private Limited (Director, since 09 Sep 2013, revenue ₹11.14 Cr (FY 2025)).
Rajasekaran Veerabadran was first appointed on 09 Sep 2013 as Director at Sunglow Lifescience Private Limited. The most recent appointment on record is 30 Aug 2024 at Adiramedica Private Limited.
The 2 current companies of Rajasekaran Veerabadran that report revenue have a combined latest revenue of ₹79.98 Cr: Sunglow Lifescience Private Limited ₹68.84 Cr (FY 2025); Sunglow Pharmaceuticalss Private Limited ₹11.14 Cr (FY 2025).
Rajasekaran Veerabadran held 2 earlier board appointments: Adiramedica Private Limited (Director, 30 Aug 2024 to 11 Aug 2025); Relimed Pharmaceuticals Private Limited (Director, from 01 Oct 2013).
The current boards of Rajasekaran Veerabadran's companies include Kamaraj (Sunglow Lifescience Private Limited), Narayanan Agaram Seetharaman (Sunglow Lifescience Private Limited), Rajasekar Nagamallu (Sunglow Lifescience Private Limited), S Arvind Bhandari (Sunglow Lifescience Private Limited).